Drug Side Effects
Search
Renal Dehydropeptidase Inhibitor [EPC]
92 reported adverse events
Drugs of this class:
IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS
These side effects are most commonly reported by patients taking drugs of the Renal Dehydropeptidase Inhibitor [EPC] class:
#
Side effect
Count
See all common reactions for Renal Dehydropeptidase Inhibitor [EPC]
Drugs of the Renal Dehydropeptidase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:
#
Side effect
Count
Frequency
See all enriched reactions for Renal Dehydropeptidase Inhibitor [EPC]